Explore Stanford technologies available for licensing:

Researchers from Stanford developed chemically modified adeno-associated virus (AAV) capsids that enable selective gene delivery to either exocrine or endocrine pancreatic cells through unnatural amino acid incorporation and peptide conjugation.